AtCor Medical Holdings Limited
Description AtCor Medical Holdings Limited, through its subsidiaries, engages in the design, manufacture, and marketing of medical devices for use in cardiovascular management. It offers SphygmoCor family of products that provides tools for non-invasive assessment of the cardiovascular system, which focuses on central blood pressures, measures of arterial stiffness, and autonomic function. The company also provides SphygmoCor CP System, a non-invasive device that provides cardiovascular measurements, including central blood pressure, aortic augmentation index, ejection duration, and subendocardial viability ratio; and SphygmoCor CPV System, which measures pulse wave velocity assessment and is used in patient care, research, and pharmaceutical clinical trials. In addition, it offers SphygmoCor CPVH System that measures central pressures assessment, pulse wave velocity, and heart rate variability; and SphygmoCor CPM System, which provides continuous real time beat-to-beat central pressures data and other cardiovascular parameters, as well as constantly monitors the changes in blood pressure by deriving central pressure through radial monitoring catheters. The company sells its products through a network of distributors. It operates primarily in Australia, the Americas, the Middle East, Africa, Asia, and New Zealand. The company has a strategic alliance with SunTech Medical, Inc. for enhancing blood pressure measurement, and cardiovascular health assessment and management. AtCor Medical Holdings is headquartered in West Ryde, Australia. To view the detailed information, you need to SUBSCRIBE with us. |
 |